Introduction Small cell lung cancer (SCLC), an aggressive subtype of lung cancer
characterized by the development of neuroendocrine tumors, is prone to distant metastasis …

7512 Background: Small cell lung cancer (SCLC) is an aggressive disease with poor
prognosis. There is an urgent need for detecting well-defined therapeutic targets, however …

Background Small cell lung cancer (SCLC) has unique biology and chromosomal
modifications; however, only a few studies have investigated the molecular map of SCLC …

Background Small cell lung cancer (SCLC) is an aggressive disease with poor survival.
Although molecular and clinical characteristics have been established for SCLC in western …

Background. Small cell lung cancer (SCLC) is an aggressive and invasive malignancy that
presents at advanced clinical stage with no more effective treatments. Development of a …

Small‐cell lung cancer (SCLC) is an exceptionally lethal malignancy characterized by
extremely high alteration rates and tumor heterogeneity, which limits therapeutic options. In …

Small cell lung cancer (SCLC) is a clinically common malignant tumor originating from the
lung neuroendocrine stem cells, which has a poor prognosis and accounts for approximately …

Background Small cell lung cancer (SCLC) is one of the deadliest malignancies and
accounts for nearly 15% of lung cancers. Previous study had revealed the genomic …

Objectives Comprehensive genomic analysis of small-cell lung cancer (SCLC) revealed
various genetic alterations. However, obtaining suitable samples for genetic analysis is …

Background Generally, small-cell lung cancer (SCLC) can be classified into central and
peripheral-type. Genomic landscape and genetic heterogeneity between central and …